Avita Medical, Inc. (RCEL) earnings
RCEL earnings moved a median of +4.56% by the close. Quarterly and annual RCEL reports and results, each read against the price at its own news timestamp. Back to the RCEL overview →
27 measured RCEL earnings events.
Where these RCEL earnings landedvs 25 measured RCEL earnings reactions
| Middle 50% of RCEL earnings reactions | -1.87% to +12.32% |
|---|---|
| Median reaction (to close) | +4.56% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 RCEL earnings events with a measured close landed between -1.87% and +12.32%; 68% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| AVITA Medical to Announce Third Quarter 2026 Financial Results | Press release | — | — | |
| AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven | Press release | +8.35% | +29.72% | |
| Form 10-Q AVITA Medical, Inc. For: Jun 30 | SEC filing · Form 10-Q | +8.35% | +29.72% | |
| AVITA Medical to Announce Second Quarter 2026 Financial Results | Press release | +0.74% | +16.79% | |
| AVITA Medical Reports First Quarter 2026 Financial Results | Press release | +12.88% | -2.15% | |
| Form 10-Q AVITA Medical, Inc. For: Mar 31 | SEC filing · Form 10-Q | +12.88% | -2.15% | |
| AVITA Medical to Announce First Quarter 2026 Financial Results | Press release | -2.07% | +2.53% | |
| Form 10-K AVITA Medical, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.73% | +13.66% | |
| AVITA® Medical Reports Third Quarter 2025 Financial Results | Press release | +0.00% | +11.87% | |
| Form 10-Q AVITA Medical, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +11.87% | |
| AVITA Medical to Announce Third Quarter 2025 Financial Results | Press release | +0.27% | -1.87% | |
| Form 10-Q AVITA Medical, Inc. For: Jun 30 | SEC filing · Form 10-Q | +6.97% | +13.94% | |
| AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation | Press release | +6.97% | +13.94% | |
| AVITA Medical to Announce Second Quarter 2025 Financial Results | Press release | +0.93% | — | |
| AVITA Medical Reports First Quarter 2025 Financial Results | Press release | -3.18% | -3.86% | |
| Form 10-Q AVITA Medical, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.18% | -3.86% | |
| AVITA Medical to Announce First Quarter 2025 Financial Results | Press release | +0.78% | +1.11% | |
| Form 10-K AVITA Medical, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.29% | +6.55% | |
| Form 10-Q AVITA Medical, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.42% | -0.42% | |
| AVITA Medical to Announce Third Quarter 2024 Financial Results | Press release | -0.25% | +4.56% | |
| Form 10-Q AVITA Medical, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.41% | +12.32% | |
| AVITA Medical to Announce Second Quarter 2024 Financial Results | Press release | +0.11% | +4.46% | |
| Form 10-Q AVITA Medical, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.63% | +9.82% | |
| AVITA Medical to Announce First Quarter 2024 Financial Results | Press release | +1.37% | +2.54% | |
| AVITA Medical Updates Expected First Quarter 2024 Revenue | Press release | -9.53% | -15.72% | |
| Form 10-K AVITA Medical, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.28% | +9.54% | |
| Form 10-Q AVITA Medical, Inc. For: Sep 30 | SEC filing · Form 10-Q | -6.67% | -5.92% |
Keep exploring
More RCEL: analyst actions → · SEC filings → · RCEL overview →